Genoptræning Danmark ApS: Financial statements 2025
CVR: 41626798
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Genoptræning Danmark ApS (CVR 41626798) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,686,355 and a net result of DKK -266,841 compared with DKK 617,783 the year before. That is a decrease of 22.7% compared with the year before. Equity in the 2025 report amounted to DKK 109,719. The solvency ratio was 6.3%.
- Gross Profit
- DKK 1,686,355
- Profit/Loss
- DKK -266,841
- Equity
- DKK 109,719
- Total Assets
- DKK 1,750,524
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.7M | -267K | 110K | - |
| 2024 | - | 2.2M | 618K | -173K | 5 |
| 2023 | - | 1.6M | 115K | -1.5M | 3 |
| 2022 | - | 503K | -365K | -1.6M | 2 |
Official annual report
How creditworthy is Genoptræning Danmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Genoptræning Danmark ApS has published its annual report for 2024. Gross profit came to DKK 2,181,472, and the net result was DKK 617,783.
About Genoptræning Danmark ApS
Genoptræning Danmark ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2020. The company is registered under the industry Andre sociale støtte- og rådgivningsaktiviteter uden institutionsophold. The management consists of Mikkel Salling Holmgaard. The company is owned by Back To Life Holding ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,686,355 and a net result of DKK -266,841 compared with DKK 617,783 the year before. Equity in the 2025 report amounted to DKK 109,719.